Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Englert

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 24, 2000
K(ATP) channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetised pigsK J Wirth, J Uhde, B Rosenstein, et al.
European Journal of Pharmacology|January 7, 1992
Airway pharmacology of the potassium channel opener, HOE 234, in guinea pigs: in vitro and in vivo studiesH C Englert, K Wirth, D Gehring, et al.
Oncogene|September 22, 1999
Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication fociO Albagli, D Lantoine, S Quief, et al.
Biochemical and Biophysical Research Communications|March 6, 1997
Oligomerization is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cellsC Ishioka, H Shimodaira, C Englert, et al.
Biochimica Et Biophysica Acta|February 8, 1997
Purification and analysis of an extremely halophilic beta-galactosidase from Haloferax alicanteiM L Holmes, R K Scopes, R L Moritz, et al.
Nature Genetics|November 14, 1997
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumourS B Lee, K A Kolquist, K Nichols, et al.
Der Unfallchirurg|February 24, 2007
[Conductive bone substitute material with variable antibiotic delivery]C Englert, P Angele, J Fierlbeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epitheliumD K Ornstein, C Englert, J W Gillespie, et al.
Science (New York, N.Y.)|December 24, 1993
WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variantD A Haber, S Park, S Maheswaran, et al.
The EMBO Journal|October 2, 1995
WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosisC Englert, X Hou, S Maheswaran, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 24, 2000
K(ATP) channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetised pigsK J Wirth, J Uhde, B Rosenstein, et al.
European Journal of Pharmacology|January 7, 1992
Airway pharmacology of the potassium channel opener, HOE 234, in guinea pigs: in vitro and in vivo studiesH C Englert, K Wirth, D Gehring, et al.
Oncogene|September 22, 1999
Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication fociO Albagli, D Lantoine, S Quief, et al.
Biochemical and Biophysical Research Communications|March 6, 1997
Oligomerization is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cellsC Ishioka, H Shimodaira, C Englert, et al.
Biochimica Et Biophysica Acta|February 8, 1997
Purification and analysis of an extremely halophilic beta-galactosidase from Haloferax alicanteiM L Holmes, R K Scopes, R L Moritz, et al.
Nature Genetics|November 14, 1997
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumourS B Lee, K A Kolquist, K Nichols, et al.
Der Unfallchirurg|February 24, 2007
[Conductive bone substitute material with variable antibiotic delivery]C Englert, P Angele, J Fierlbeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epitheliumD K Ornstein, C Englert, J W Gillespie, et al.
Science (New York, N.Y.)|December 24, 1993
WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variantD A Haber, S Park, S Maheswaran, et al.
The EMBO Journal|October 2, 1995
WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosisC Englert, X Hou, S Maheswaran, et al.
Pageof 9